Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Assets Average: 2020-2025

Historic Assets Average for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to $1.7 billion.

  • Legend Biotech's Assets Average fell 3.71% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 3.71%. This contributed to the annual value of $1.8 billion for FY2024, which is 10.67% up from last year.
  • Latest data reveals that Legend Biotech reported Assets Average of $1.7 billion as of Q3 2025, which was up 2.94% from $1.7 billion recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Assets Average peaked at $1.9 billion during Q3 2023, and registered a low of $361.4 million during Q1 2021.
  • Over the past 3 years, Legend Biotech's median Assets Average value was $1.7 billion (recorded in 2024), while the average stood at $1.7 billion.
  • Per our database at Business Quant, Legend Biotech's Assets Average surged by 113,898.34% in 2021 and then declined by 9.33% in 2025.
  • Legend Biotech's Assets Average (Quarterly) stood at $966.6 million in 2021, then skyrocketed by 199.38% to $1.1 billion in 2022, then increased by 17.41% to $1.8 billion in 2023, then fell by 7.65% to $1.7 billion in 2024, then dropped by 3.71% to $1.7 billion in 2025.
  • Its Assets Average stands at $1.7 billion for Q3 2025, versus $1.7 billion for Q2 2025 and $1.6 billion for Q1 2025.